Taurolidine
Top View
- Ep 0253662 A1
- Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
- Efficacy of Taurolidine Against Periodontopathic Species—An in Vitro Study
- Orphan Drug Designation List
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- Taurolidine-Based Catheter Lock Regimen Significantly
- Ep 0253662 B1
- Promising Drug Candidates and New Strategies for Fighting Against the Emerging Superbug Candida Auris
- Methods for Preventing Central Line Associated Bloodstream Infection in Pediatric Hematology-Oncology Patients: a Systematic Literature Review, 2010-2020
- WO 2U11/132171 Al
- Antimicrobial Locks in Patients Receiving Home Parenteral Nutrition
- As) United States A2) Patent Application Publication Co) Pub. No.: US 2015/0313221 Al Piotrowski Et Al
- Pharmaceutical Appendix to the Tariff Schedule 2
- Rxoutlook® 1St Quarter 2021
- (12) Patent Application Publication (10) Pub. No.: US 2015/0335707 A1 Swamynathan Et Al
- Harmonized Tariff Schedule of the United States (2006) (Rev
- (12) United States Patent (10) Patent No.: US 6,331,289 B1 Klaveness Et Al
- Taurolidine-Citrate-Heparin Lock Reduces Catheter-Related